.png)
NEW ORLEANS — For people with type 2 diabetes (T2D) inadequately controlled on submaximal dulaglutide (Trulicity) doses, switching to tirzepatide (Mounjaro) produces significantly greater A1c and weight lowering than does escalating dulaglutide treatment. “Often, when we are with a patient who is not meeting treatment goals...
.png)
4336 Plainfield Ave ne Grand Rapids Michigan 49525
16162083711
fitlifehere@gmail.com
Copyright © 2023 fitlife. All Rights Reserved
